Literature DB >> 1699108

K88 fimbriae as carriers of heterologous antigenic determinants.

D Bakker1, F G van Zijderveld, S van der Veen, B Oudega, F K de Graaf.   

Abstract

The K88 fimbriae of enterotoxigenic Escherichia coli are strongly immunogenic antigens that can be used to evoke protective immunity. To find out whether these fimbriae can be used as carriers for foreign epitopes, a highly variable region present in the primary structure of the different K88 variants was replaced with five different heterologous epitopes to investigate to what extent these insertions affected the expression, assembly (biogenesis), stability and immunogenic properties of the resulting hybrid fimbriae. Amino acid residues 163-173, were replaced using site-directed in vitro mutagenesis and the hybrid fimbriae were tested for these aspects using ELISA, immunoelectronmicroscopy and immunoblotting. Replacement of this highly variable region did not affect the biosynthesis of fimbriae, although all mutations tested resulted in a reduced expression depending on the epitope inserted. Testing of the different hybrid fimbriae with a panel of monoclonal antibodies raised against the various K88 serotypes K88ab, K88ac and K88ad indicated that replacement of amino acid sequence 163-173 did not affect conserved or K88ab specific epitopes but the K88ac and K88ad specific conformation was lost. Immunization with hybrid fimbriae raises antibodies specific for the inserted heterologous epitopes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699108     DOI: 10.1016/0882-4010(90)90093-6

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  10 in total

1.  CS31A capsule-like antigen as an exposure vector for heterologous antigenic determinants.

Authors:  F Bousquet; C Martin; J P Girardeau; M C Méchin; M Der Vartanian; H Laude; M Contrepois
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

2.  Mapping the Neutralizing Epitopes of Enterotoxigenic Escherichia coli K88 (F4) Fimbrial Adhesin and Major Subunit FaeG.

Authors:  Ti Lu; Rodney A Moxley; Weiping Zhang
Journal:  Appl Environ Microbiol       Date:  2019-05-16       Impact factor: 4.792

Review 3.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

Review 4.  Fimbriae-assisted bacterial surface display of heterologous peptides.

Authors:  P Klemm; M A Schembri
Journal:  Int J Med Microbiol       Date:  2000-07       Impact factor: 3.473

5.  Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.

Authors:  H Chen; D M Schifferli
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Polymeric display of immunogenic epitopes from herpes simplex virus and transmissible gastroenteritis virus surface proteins on an enteroadherent fimbria.

Authors:  D B Rani; M E Bayer; D M Schifferli
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

7.  Characterization of the binding specificity of K88ac and K88ad fimbriae of enterotoxigenic Escherichia coli by constructing K88ac/K88ad chimeric FaeG major subunits.

Authors:  Weiping Zhang; Ying Fang; David H Francis
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

8.  Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.

Authors:  Chengxian Zhang; Weiping Zhang
Journal:  Clin Vaccine Immunol       Date:  2010-10-27

Review 9.  Swine and cattle enterotoxigenic Escherichia coli-mediated diarrhea. Development of therapies based on inhibition of bacteria-host interactions.

Authors:  M Mouricout
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

10.  Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

Authors:  C K Stover; G P Bansal; M S Hanson; J E Burlein; S R Palaszynski; J F Young; S Koenig; D B Young; A Sadziene; A G Barbour
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.